Buy Repatha SureClick (evolocumab) Online For Sale
$588.00
DISEASE INDICATIONS: Risk of cardiovascular events, Hypercholesterolemia
MANUFACTURER: Amgen Inc.
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Repatha (evolocumab) is a medication used to lower LDL cholesterol levels. It works by binding to PCSK9 which increases the number of LDL receptors on the liver resulting in a decrease in LDL cholesterol levels. It was approved by the FDA in 2015 and is usually used for patients in high cardiovascular risk or familial hypercholesterolemia.